OBJECTIVE: A functional polymorphism in the chemokine receptor CX3CR1 is associated with protection from vascular diseases including coronary artery disease and internal carotid artery occlusive disease. We investigated the mechanisms by which CX3CR1 may be involved by evaluating the inflammatory response to arterial injury in CX3CR1-deficient animals. METHODS AND RESULTS: Femoral arteries of CX3CR1-/- and wild-type (WT) mice were injured with an angioplasty guide wire. After 1, 5, 14, and 28 days, arteries were harvested and evaluated by histology, morphometry, and immunohistochemistry. Arterial injury upregulated the CX3CR1 ligand CX3CL1. In CX3CR1-/- compared with WT animals, the incidence of neointima formation was 58% lower (P=0.0017), accompanied by no difference in the area of platelet accumulation at day 1 (P=0.48) but a significant decrease in intimal monocyte infiltration at day 5 (P=0.006), vascular smooth muscle cell (VSMC) proliferation at days 5 and 14, and intimal area at day 28 (P=0.009). CONCLUSIONS: In an endothelial denudation injury model, CX3CR1 deficiency protects animals from developing intimal hyperplasia as a result of decreased monocyte trafficking to the lesion. CX3CR1 deficiency decreases VSMC proliferation and intimal accumulation either directly or indirectly as a result of defective monocyte infiltration.
OBJECTIVE: A functional polymorphism in the chemokine receptor CX3CR1 is associated with protection from vascular diseases including coronary artery disease and internal carotid artery occlusive disease. We investigated the mechanisms by which CX3CR1 may be involved by evaluating the inflammatory response to arterial injury in CX3CR1-deficient animals. METHODS AND RESULTS: Femoral arteries of CX3CR1-/- and wild-type (WT) mice were injured with an angioplasty guide wire. After 1, 5, 14, and 28 days, arteries were harvested and evaluated by histology, morphometry, and immunohistochemistry. Arterial injury upregulated the CX3CR1 ligand CX3CL1. In CX3CR1-/- compared with WT animals, the incidence of neointima formation was 58% lower (P=0.0017), accompanied by no difference in the area of platelet accumulation at day 1 (P=0.48) but a significant decrease in intimal monocyte infiltration at day 5 (P=0.006), vascular smooth muscle cell (VSMC) proliferation at days 5 and 14, and intimal area at day 28 (P=0.009). CONCLUSIONS: In an endothelial denudation injury model, CX3CR1 deficiency protects animals from developing intimal hyperplasia as a result of decreased monocyte trafficking to the lesion. CX3CR1deficiency decreases VSMC proliferation and intimal accumulation either directly or indirectly as a result of defective monocyte infiltration.
Authors: Teresa K Tarrant; Peng Liu; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Roman G Timoshchenko; Marcus W McGinnis; David J Fitzhugh; Dhavalkumar D Patel; Alan M Fong Journal: Arthritis Rheum Date: 2012-05
Authors: Elisabeth A Lasater; Fang Li; Waylan K Bessler; Myka L Estes; Sasidhar Vemula; Cynthia M Hingtgen; Mary C Dinauer; Reuben Kapur; Simon J Conway; David A Ingram Journal: J Clin Invest Date: 2010-02-15 Impact factor: 14.808
Authors: Felix Becker; Christina Holthoff; Christoph Anthoni; Emile Rijcken; J Steven Alexander; Felicity N E Gavins; H U Spiegel; Norbert Senninger; Thorsten Vowinkel Journal: Int J Colorectal Dis Date: 2016-12-10 Impact factor: 2.571
Authors: Manikandan Panchatcharam; Sumitra Miriyala; Fanmuyi Yang; Mauricio Rojas; Christopher End; Christopher Vallant; Anping Dong; Kevin Lynch; Jerold Chun; Andrew J Morris; Susan S Smyth Journal: Circ Res Date: 2008-08-14 Impact factor: 17.367
Authors: Jennifer C Sullivan; Jennifer L Pardieck; Derek Doran; Yan Zhang; Jin-Xiong She; Jennifer S Pollock Journal: Am J Physiol Heart Circ Physiol Date: 2009-02-06 Impact factor: 4.733
Authors: J D Hall; S L Kurtz; N W Rigel; B M Gunn; S Taft-Benz; J P Morrison; A M Fong; D D Patel; M Braunstein; T H Kawula Journal: Clin Exp Immunol Date: 2009-02-10 Impact factor: 4.330